Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...

A late-stage melanoma vaccine report that was posted online and quickly pulled is driving a violent repricing in Moderna ...

It has been a volatile year for the biotech.

Subscribe to our WhatsApp Channel Many Sri Lankans took the Pfizer-BioNTech vaccine during the pandemic, so a post claiming ...

Pfizer PFE will announce its third-quarter 2026 earnings on Nov. 3, and investors will be watching the performance of its oncology business closely, as the segment generates nearly 27% of the ...

It comes after an immunisation program shake-up, with providers now able to set the price at their discretion.

Covid-19 vaccination will be added to Singapore’s national childhood and adult immunisation schedules from Oct 12, with updated vaccines to be rolled out at more than 600 GP clinics, all polyclinics ...

Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the ...

VACCINE LAWSUIT  Florida's Attorney General is suing a major drugmaker, saying it misled patients about the benefits of its COVID-19 vaccine.

Targeted Formulations' in the Context of Japanese Clinical PracticeThe key point of this news is the update of antigens to match the circulating virus. However, it is necessary to distinguish between ...

Florida Attorney General James Uthmeier filed a lawsuit Thursday against Pfizer Inc., alleging unfair and deceptive marketing of Pfizer’s COVID-19 vaccine. The suit, filed in state trial court in St.

About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data ...